CADL
Candel Therapeutics, Inc.
Latest Form 4:Sale$84KbyTyagarajan Seshu (Chief Technology Officer) · filed Aug 19, 2026
Candel Therapeutics, Inc. (CADL) has 4 SEC Form 4 filings (4 transaction rows) in the rolling window, disclosed by 3 distinct insiders. Most recent filing: Aug 19, 2026.
Inside the rolling window, 3 insiders at Candel Therapeutics, Inc. reported 1 open-market purchase totaling $3.0M and 3 open-market sales totaling $390K. Insiders have net bought $2.6M over the trailing 6 months. The largest single insider purchase in this window was $3.0M by Director Manning Paul B on Feb 23, 2026. The most recent open-market filing is a sale of 7,000 shares by Chief Technology Officer Tyagarajan Seshu, dated Aug 17, 2026, worth $84K.
- Industry:Biotechnology
- CEO:Paul-Peter Tak
- Employees:55
- HQ:Needham, MA, US
- IPO:2021-07-27
Insider Buying
$3.0M
reported purchases (SEC code P)
Insider Selling
$390K
reported sales (SEC code S)
Unique Insiders
3
in the rolling window
Market Cap
$983.3M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| Chief Technology Officer | Sale | 7,000 | $84K | Aug 19 | SEC ↗ | |
Tyagarajan SeshuFirst filing | Chief Technology Officer | Sale | 7,000 | $70K | Jul 1 | SEC ↗ |
Barone FrancescaFirst filing | Chief Scientific Officer | Sale | 23,447 | $236K | Jul 1 | SEC ↗ |
Manning Paul BFirst in 3 months | Director | Purchase | 550,458 | $3.0M | Feb 26 | SEC ↗ |
Frequently asked questions
How many SEC Form 4 insider filings does CADL have?
Candel Therapeutics, Inc. (CADL) has 4 SEC Form 4 filings (4 transaction rows) in the rolling 365-day window, disclosed by 3 distinct insiders. Most recent filing: Aug 19, 2026.
When was the most recent SEC Form 4 filing for CADL?
The most recent Form 4 filing for CADL on Tracefour is dated Aug 19, 2026.
What is the net insider flow at CADL over the last 6 months?
Over the trailing 180 days, insiders at CADL have net bought $2.6M based on SEC Form 4 disclosures.
What was the largest insider purchase at CADL?
The largest single insider open-market purchase at CADL in the rolling window was $3.0M by Director Manning Paul B on 2026-02-23.
What is the total insider buy and sell value at CADL in the current window?
Inside the rolling window, insiders at CADL bought $3.0M and sold $390K based on SEC Form 4 filings.
Can I get alerts for CADL insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Candel Therapeutics, Inc. (CADL). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Candel Therapeutics, Inc. is in the Healthcare sector.